20231-36-1

Basic information

• Product Name: METHYL-6-O-TRIPHENYLMETHYL-ALPHA-D-MANNOPYRANOSIDE
• Synonyms: METHYL-6-O-TRIPHENYLMETHYL-ALPHA-D-MANNOPYRANOSIDE;Methyl-6-O-trityl-alpha-D-mannopyranoside
• CAS NO: 20231-36-1
• Molecular Formula: C₂₆H₂₈O₆
• Molecular Weight: 436.5
• Mol File: 20231-36-1.mol
• Article Data: 42

Chemical Properties

• Boiling Point: 593.3±50.0 °C(Predicted)
• Appearance: /
• Density: 1.30±0.1 g/cm3(Predicted)
• PKA: 12.89±0.70(Predicted)
• CAS DataBase Reference: METHYL-6-O-TRIPHENYLMETHYL-ALPHA-D-MANNOPYRANOSIDE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL-6-O-TRIPHENYLMETHYL-ALPHA-D-MANNOPYRANOSIDE(20231-36-1)
• EPA Substance Registry System: METHYL-6-O-TRIPHENYLMETHYL-ALPHA-D-MANNOPYRANOSIDE(20231-36-1)

Safety Data

• Hazardous Substances Data: 20231-36-1(Hazardous Substances Data)

Upstream product

• 76-83-5 trityl chloride 
• 3396-99-4 methyl α-D-galactopyranoside 
• 86172-85-2 methyl 3,6-di-O-trityl-α-D-galactopyranoside 
• 86172-84-1 (2R,3R,4S,5R,6S)-6-Methoxy-5-trityloxy-2-trityloxymethyl-tetrahydro-pyran-3,4-diol 
• 53685-07-7 Methyl 3,4-O-isopropylidene-6-O-triphenylmethyl-α-D-galactopyranoside 
• 1824-94-8 methyl beta-D-galactopyranoside 
• 87591-35-3 Methyl 2,3,4-tri-O-acetyl-6-O-trityl-β-D-galactopyranoside 
• 617-04-9 (2R,3S,4S,5S,6S)-2-(hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol 
• 86172-79-4 (2S,3S,4S,5R,6R)-2-Methoxy-4-trityloxy-6-trityloxymethyl-tetrahydro-pyran-3,5-diol 
• 86172-80-7 (2S,3S,4R,5S,6R)-2-Methoxy-5-trityloxy-6-trityloxymethyl-tetrahydro-pyran-3,4-diol 
• 86172-78-3 (2R,3S,4S,5S,6S)-6-Methoxy-5-trityloxy-2-trityloxymethyl-tetrahydro-pyran-3,4-diol 
• 530-26-7 D-Mannose 

Downstream Products

• 18685-19-3 methyl 2,3,4-tri-O-benzyl-6-O-trityl-α-D-galactopyranoside 
• 40653-30-3 methyl 2,3,4-tri-O-benzyl-6-O-triphenylmethyl-β-D-galactopyranoside 
• 34698-24-3 methyl 3,4-O-isopropylidene-6-O-trityl-β-D-galactopyranoside 
• 128784-99-6 (2S,3S,4S,5R,6R)-4-[(Dimethyl-phenyl-silanyl)-methoxymethoxy]-2-methoxy-6-trityloxymethyl-tetrahydro-pyran-3,5-diol 
• 53767-29-6 methyl 4-O-acetyl-2,3-di-O-methyl-6-O-trityl-α-D-mannopyranoside 
• 88299-90-5 methyl 3-O-acetyl-2,4-di-O-methyl-6-O-trityl-α-D-mannopyranoside 
• 88299-89-2 methyl 2,4-di-O-acetyl-4-O-methyl-6-O-trityl-α-D-mannopyranoside 
• 88299-88-1 methyl 2,4-di-O-acetyl-3-O-methyl-6-O-trityl-α-D-mannopyranoside 
• 2595-06-4 (2S,3S,4S,5R,6R)-3,4,5-Tris-benzyloxy-2-methoxy-6-trityloxymethyl-tetrahydro-pyran 
• 16802-89-4 methyl 2,3-di-O-mesyl-6-O-trityl-α-D-mannopyranoside 
• 101703-39-3 methyl 2,3,4-tri-O-allyl-6-O-trityl-α-D-mannopyranoside 
• 23089-65-8 methyl 2-O-methyl-6-O-trityl-α-D-mannopyranoside 
• 84856-56-4 methyl 3-O-methyl-6-O-trityl-α-D-mannopyranoside 
• 27299-03-2 methyl 2,3-di-O-methyl-6-O-trityl-α-D-mannopyranoside 

Relevant articles and documents

USE OF MANNOSE 6 PHOSPHATE AND MODIFICATIONS THEREOF FOR MEMORY ENHANCEMENT AND REDUCING MEMORY IMPAIRMENT

Provided are compositions and methods for memory enhancement, including recovery of memory impairment. The compositions and methods relate to mannose-6-phosphate and derivatives of mannose-6-phosphate. The methods relate to administration of M6P or derivatives thereof to individuals in whom memory enhancement is desired.

USE OF IGF-2 RECEPTOR AGONIST LIGANDS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM

Provided are methods for treatment of neurodevelopmental disorders, such as Angelman Syndrome and autism comprising administering to an individual a composition comprising an agonist ligand of IGF -2 receptor. The agonist ligand of IGF-2 receptor may be IGF -2, or mannose-6-phosphate or a derivative thereof. Compositions comprising mannose-6-phosphate derivatives are also disclosed.

Visible-Light-Mediated, Chemo- and Stereoselective Radical Process for the Synthesis of C-Glycoamino Acids

An approach for efficient synthesis of C-glycosyl amino acids is described. Different from typical photoredox-catalyzed reactions of imines, the new process follows a pathway in which α-imino esters serve as electrophiles in chemoselective addition reactions with nucleophilic glycosyl radicals. The process is highlighted by the mild nature of the reaction conditions, the highly stereoselectivity attending C-C bond formation, and its applicability to C-glycosylations using both armed and disarmed pentose and hexose derivatives.